Pharmaceutical

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.

Jul 15, 2023 - 20:00
Vistagen obtains Canadian Notice of Allowance for AV-101 patent
Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.
Read the original article

Tags:

Previous Article

Theseus terminates its GI cancer drug development programme

Next Article

Gilead, CHAI and Penta to enhance HIV treatment for children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

NexImmune to lay off over half of its employees

NexImmune to lay off over half of its employees

Sep 1, 2023

Opinion: New draft recommendations for mammograms take a one-size-fits-all approach

Opinion: New draft recommendations for mammograms take ...

May 17, 2023

STAT+: Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa

STAT+: Alkermes shareholders re-elect directors, rebuff...

Jun 30, 2023